Matches in Wikidata for { <http://www.wikidata.org/entity/Q65346629> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q65346629 description "clinical trial" @default.
- Q65346629 description "ensayu clínicu" @default.
- Q65346629 description "klinisch onderzoek" @default.
- Q65346629 description "клінічне випробування" @default.
- Q65346629 name "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 name "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 type Item @default.
- Q65346629 label "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 label "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 prefLabel "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 prefLabel "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 P1050 Q65346629-2DFA66AC-4C81-4BD7-9D81-41DE94EABFF7 @default.
- Q65346629 P1050 Q65346629-8FDAC6BE-335F-4FBE-8966-90BDF65E3516 @default.
- Q65346629 P1132 Q65346629-3602C8B5-A6A0-41D6-8F52-3BB5D409329D @default.
- Q65346629 P1476 Q65346629-EE6D4B66-A3BD-4195-B821-17A436745DAA @default.
- Q65346629 P17 Q65346629-C3200CAC-B85F-4E4A-8CC6-0B61517FFD09 @default.
- Q65346629 P2899 Q65346629-62871A02-1EF2-49A9-B2B6-6BE9E6726925 @default.
- Q65346629 P3098 Q65346629-21E84268-486B-42B4-A9DA-864E80B7267D @default.
- Q65346629 P31 Q65346629-D2E4B3F7-A064-4C2B-9C44-7DB0C8AB6EA6 @default.
- Q65346629 P4844 Q65346629-18FAE6E0-0818-4F5F-AEC9-D24B923DA2FF @default.
- Q65346629 P4844 Q65346629-39CE0857-3B60-4E82-9DC2-EECE69DF481B @default.
- Q65346629 P4844 Q65346629-BADA7769-A59F-43A8-AF4D-65037E0BCA1D @default.
- Q65346629 P4844 Q65346629-DCEA441B-ADD0-44B6-B5CC-D6ECF787E264 @default.
- Q65346629 P580 Q65346629-9463F492-05FC-4627-9EEA-2624CE44720F @default.
- Q65346629 P582 Q65346629-5DA72001-7F51-4F80-A8A4-1109A0586A02 @default.
- Q65346629 P6099 Q65346629-8491A8EF-B2BA-4DA5-BDB4-0EDBEA4C7D00 @default.
- Q65346629 P6153 Q65346629-6D3A7368-6609-4424-AFEF-12C7B63921EC @default.
- Q65346629 P8363 Q65346629-DFCDCCD3-BC69-4E89-88E1-074504108988 @default.
- Q65346629 P1050 Q127076 @default.
- Q65346629 P1050 Q186889 @default.
- Q65346629 P1132 "+552" @default.
- Q65346629 P1476 "A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose, Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Pain and Opioid-Induced Nausea and Vomiting (OINV)" @default.
- Q65346629 P17 Q30 @default.
- Q65346629 P2899 "+18" @default.
- Q65346629 P3098 "NCT02462811" @default.
- Q65346629 P31 Q30612 @default.
- Q65346629 P4844 Q411441 @default.
- Q65346629 P4844 Q413486 @default.
- Q65346629 P4844 Q422970 @default.
- Q65346629 P4844 Q57055 @default.
- Q65346629 P580 "2014-09-01T00:00:00Z" @default.
- Q65346629 P582 "2015-07-01T00:00:00Z" @default.
- Q65346629 P6099 Q42824827 @default.
- Q65346629 P6153 Q49117 @default.
- Q65346629 P8363 Q78089383 @default.